Astrana Health closed at $39.01 on Nov 5, down 1.66%, 21.7% below its 52-week closing high. Volume of 530.3K shares was 1.83× its 20-day average (above normal).
Split-adjusted performance: +5.0% over one month, +8.1% over six months, +17.9% over one year.
In the quarter ended Jun 30, 2026, revenue was $972.52M, up 48.5% from a year earlier, with a net margin of 2.0%.
Short interest was 3.0M shares at the Oct 15 settlement, down 2.5% from the prior report (6.8% of float, 8.8 days to cover).